(Q24290411)

GOA release 2020-03-11

complement binding

1 reference

Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21)

GOA release 2020-03-11

author name string

L Clemenza

series ordinal

1

0 references

D E Isenman

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 October 2000

0 references

published in

Journal of Immunology

0 references

volume

165

0 references

issue

7

0 references

page(s)

3839-48

0 references

cites work

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Solution structure of a pair of complement modules by nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

The regulators of complement activation (RCA) gene cluster

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Enhanced molecular mimicry of CEA using photoaffinity crosslinked C3d peptide

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

The unactivated form of the first component of human complement, C1

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Expression of a synthetic bovine rhodopsin gene in monkey kidney cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Structure-function analysis of the active sites of complement receptor type 1

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35).

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Antibody response to a T-dependent antigen requires B cell expression of complement receptors

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

The role of complement and complement receptors in induction and regulation of immunity.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021

The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.165.7.3839

7 January 2021